Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Kane Biotech Inc (KNE.VN)

Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 5,857
  • Shares Outstanding, K 167,347
  • Annual Sales, $ 2,081 K
  • Annual Income, $ 6,098 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.60
  • Price/Sales 11.52
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.08
  • Most Recent Earnings $0.00 on 11/28/25
  • Next Earnings Date 04/27/26
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING TSX Biotechnology

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.035 unch
on 03/09/26
0.040 -12.50%
on 03/04/26
-0.005 (-12.50%)
since 02/09/26
3-Month
0.030 +16.67%
on 12/18/25
0.045 -22.22%
on 01/22/26
unch (unch)
since 12/10/25
52-Week
0.025 +40.00%
on 11/04/25
0.115 -69.57%
on 03/21/25
-0.055 (-61.11%)
since 03/10/25

Most Recent Stories

More News
Kane Biotech Expands U.S. Commercial Footprint with Strategic Distribution Partnership

WINNIPEG, Manitoba, March 10, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (Kane or the Company), transforming wound care with three FDA 510(k) cleared and two Health Canada approved formats, is pleased...

KNE.VN : 0.035 (unch)
KNBIF : 0.0260 (-3.70%)
Kane Biotech Announces Publication of revyve® Wound Gel Article in the International Wound Journal

WINNIPEG, Manitoba, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE) (“Kane Biotech” or “Kane”) announces the publication of an article on its revyve ® Antimicrobial wound gel...

KNE.VN : 0.035 (unch)
KNBIF : 0.0260 (-3.70%)
Kane Biotech Expands Commercial Activities in the United States

WINNIPEG, Manitoba, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech” or the “Company”) today announces that it has signed non-exclusive distribution/sales agreements...

KNE.VN : 0.035 (unch)
KNBIF : 0.0260 (-3.70%)
Kane Biotech Announces FDA 510(k) Clearance for revyve® Antimicrobial Skin and Wound Cleanser

WINNIPEG, Manitoba, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSXV:KNE) (“Kane Biotech”. “Kane” or the “Company”) today announces two regulatory milestones that strengthen the...

KNE.VN : 0.035 (unch)
KNBIF : 0.0260 (-3.70%)
Kane Biotech Restarts Commercial Activities and Strengthens North American Management

WINNIPEG, Manitoba, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announces the resumption of commercial activities in both...

KNE.VN : 0.035 (unch)
KNBIF : 0.0260 (-3.70%)
Kane Biotech Announces Closing of Private Placement Offering with an Insider of the Company

WINNIPEG, Manitoba, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) announces that today it has completed its previously announced...

KNE.VN : 0.035 (unch)
KNBIF : 0.0260 (-3.70%)
Kane Biotech Presents New Data at Innovations in Wound Healing Annual Meeting

WINNIPEG, Manitoba, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) announces that it presented new clinical and scientific data...

KNE.VN : 0.035 (unch)
KNBIF : 0.0260 (-3.70%)
Kane Biotech Receives Health Canada Approval for revyve® Antimicrobial Wound Gel Spray

WINNIPEG, Manitoba, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announces that Health Canada has approved its revyve ®...

KNE.VN : 0.035 (unch)
KNBIF : 0.0260 (-3.70%)
Kane Biotech Announces Third Quarter 2025 Financial Results

WINNIPEG, Manitoba, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announced its third quarter 2025 financial results. ...

KNE.VN : 0.035 (unch)
KNBIF : 0.0260 (-3.70%)
Kane Biotech Announces New Private Placement Offering

Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, Nov. 27, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane”...

KNE.VN : 0.035 (unch)
KNBIF : 0.0260 (-3.70%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise...

See More

Key Turning Points

3rd Resistance Point 0.035
2nd Resistance Point 0.035
1st Resistance Point 0.035
Last Price 0.035
1st Support Level 0.035
2nd Support Level 0.035
3rd Support Level 0.035

See More

52-Week High 0.115
Fibonacci 61.8% 0.081
Fibonacci 50% 0.070
Fibonacci 38.2% 0.059
Last Price 0.035
52-Week Low 0.025

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar